Status:

TERMINATED

Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting

Lead Sponsor:

Riverside University Health System Medical Center

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

The goal of the current study is to determine difference in glycemic control between traditional split mix regimen with Neutral Protamine Hagedorn (NPH) and regular insulin vs basal bolus regimen with...

Detailed Description

The effect of insulin depends not only on the pharmacokinetics and pharmacodynamics of a particular preparation, but also on patient specific factors which includes state of inflammation, obesity etc....

Eligibility Criteria

Inclusion

  • Patients with type II diabetes regardless of duration of diagnosis with an admission blood glucose level between 140 mg/dL to 400 mg/dL will be included in the study.
  • Other inclusion criteria are as follows:
  • age 18-80 years old
  • treated with diet alone
  • any combination of oral anti-diabetic agents or insulin treatment with any dosage before admission.

Exclusion

  • Hyperglycemia without a known history of diabetes
  • H/o recent cardiac surgery (within 6 months)
  • Impaired renal function (glomerular filtration rate less than 45)
  • History of diabetic ketoacidosis
  • Diabetes mellitus type 1
  • Pregnancy
  • Patients on steroid treatment
  • Known hypopituitarism or adrenal insufficiency
  • Known hypoglycemia of unawareness
  • Length of stay \<48 h
  • And severe liver disease and patent admitted in intensive care unit.
  • Patients already received an insulin dose greater than 0.5 units/kg body weight after admission prior to initiation of study protocol will be excluded from the study.

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2017

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT02189395

Start Date

April 1 2013

End Date

April 1 2017

Last Update

September 28 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Riverside County Regional Medical Center

Moreno Valley, California, United States, 92555